Skip to Content
Biotechnology and health

The fight over who owns CRISPR is back, and it’s a rematch

USPTO signage
USPTO signageReubenGBrewer, Wikimedia

The dispute over valuable patents to the gene-editing tool CRISPR is back on, and the belligerents are once again the Broad Institute of Cambridge, Massachusetts, and the University of California, reports STAT News.

The dispute: It’s all about money, power, and scientific credit. In short, it’s about who really invented CRISPR gene editing, a simple way to modify the DNA inside cells that’s swept the world and could be the basis for a new generation of gene-therapy treatments.

The sides: In one corner, UC Berkeley, where biochemist Jennifer Doudna was part of a team that in 2012 described a CRISPR editor able to zap DNA in a test tube. In the other, the Broad Institute of MIT /Harvard, a genomics juggernaut whose star scientist, Feng Zhang, was among the first to use CRISPR to edit human DNA.

The news: This week, the US Patent Office opened an “interference” proceeding. That means it’s going to take a bundle of patents and patent applications it thinks cover the same inventions and, following a court-like legal proceeding, potentially shift rights around among the feuding parties.

It’s not the first interference involving CRISPR patents. In a previous round, the Broad Institute prevailed when the patent office ruled that making CRISPR work inside human cells—not only in a test tube—was a distinct and separate invention. That meant Broad’s key patents stayed in place. For the time being.

Now that it's clear that CRISPR in human cells is its own thing, a new challenge begins. The patent office needs to sort out a thicket of competing and conflicting claims and figure out who the invention should belong to.  

According to case documents, it’s up to the Broad Institute to avoid further trouble (and lawyer fees) by initiating settlement agreements with Berkeley. So far the parties haven't been able to reach a truce.

Deep Dive

Biotechnology and health

This baby with a head camera helped teach an AI how kids learn language

A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

The next generation of mRNA vaccines is on its way

Adding a photocopier gene to mRNA vaccines could make them last longer and curb side effects.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.